Camrelizumab Combined With Apatinib in the Treatment of Patients With Advanced Gastric Cancer and Colorectal Cancer
Clinical trial NCT04067986 · UNKNOWN
Trial details
- NCT number
- NCT04067986
- Sponsor
- Zhongshan Hospital Xiamen University
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-20
- Primary completion
- 2020-09-23
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.